Venture capital firms Clarus Ventures and Takeda Ventures have backed a $21m round for UK-based drug discovery and development company Heptares Therapeutics, alongside the Stanley Family Foundation.
Existing investors including Softbank and Lakestar reinvest in the tourism booking platform
Andera has reinvested and Prenax has acquired LM Information's subscription management business
Sale ends a six-year holding period for KCP, which backed the company with a £3.3m investment
Danish internet company could reportedly be listed at a valuation of $1bn